Key management emerges as a delivery risk in automotive software

Tern plc

As vehicle architectures transition toward software-defined platforms, cryptographic key management is becoming an embedded engineering concern rather than a background cybersecurity task. Software capabilities now define product differentiation in the automotive sector, and this shift is placing new demands on how manufacturers secure, update and validate the integrity of vehicle systems over their full lifecycle.

In earlier automotive cycles, security architectures were simpler. Vehicles had a small number of electronic control units, updates were infrequent, and keys or certificates could be handled manually or with limited automation. As manufacturers expanded into more complex platforms, identity provisioning processes evolved separately across engineering, cloud infrastructure and manufacturing lines.

This fragmentation is now surfacing as a structural constraint across large-scale vehicle programmes. Certificates expire unpredictably, sometimes disabling update functions in fleets already in service. Keys injected during manufacturing may not be recognised by cloud services due to misaligned trust models. Firmware from one generation of hardware may not be signed in a way that is compatible with another, even within the same vehicle line.

In the absence of structured key management, engineering teams may need to pause launches or rework production lines to meet compliance.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority addresses security risks as AI takes control of physical machines

Device Authority's KeyScaler platform supports secure AI-driven automation by helping organisations authenticate connected machines, protect device identities and control access to physical equipment.

Talking Medicines examines factors influencing prescribing decisions

Talking Medicines explains how healthcare professional conversations, clinical considerations and treatment perceptions can provide pharmaceutical companies with deeper insight into prescribing intent beyond traditional campaign metrics.

What HCPs say could reveal prescribing intent

Talking Medicines is using AI to analyse HCP conversations and identify the clinical and practical factors that may influence prescribing intent.

AI control of machines raises new security questions

AI is gaining the ability to control physical equipment, but establishing that machines are genuine, authorised and secure will be an important part of making this technology safe to deploy.

CAR-T therapy brings new approach to multiple myeloma treatment

CAR-T therapy is being used in multiple myeloma and is being studied earlier in the treatment pathway, with research focused on improving durability, safety and access.

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

Search